UK Companies House feature
MANCHESTER FERTILITY SERVICES LIMITED.
Cash
£2M
+140.1% vs 2024
Net assets
£2M
+66.7% vs 2024
Employees
90
+2.3% vs 2024
Profit before tax
£1M
+105.2% vs 2024
Profile
- Company number
- 01902981
- Status
- Active
- Incorporation
- 1985-04-09
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86220
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2025-03-31
| Metric | Trend | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £525,021 | £1,077,334 | |
| Net profit | — | — | — | — | £323,208 | £917,499 | |
| Cash | £68,897 | £568,192 | £604,165 | — | £714,377 | £1,715,036 | |
| Total assets less current liabilities | £950,822 | £862,179 | £1,153,012 | — | £1,291,402 | £2,054,101 | |
| Net assets | £169,524 | £405,792 | £1,033,646 | — | £1,163,971 | £1,939,970 | |
| Equity | £169,524 | £405,792 | £1,033,646 | — | £1,163,971 | £1,939,970 | |
| Average employees | 65 | 67 | 81 | — | 88 | 90 | |
| Wages | — | — | — | — | £4,228,453 | £4,858,098 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Lopian Gross Barnett & Co
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The Company plans investment in clinical capacity, donor services, research collaborations, and improved digital patient engagement and AI tools in the clinical areas.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FALCONER, Deborah, Dr | Director | 2012-03-29 | May 1959 | British |
| KOSLOVER, Jonathan | Director | 2012-03-29 | Feb 1960 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LEE, Paul Anthony | Secretary | — | 2004-07-05 |
| LIEBERMAN, Gemma | Secretary | 2012-03-29 | 2018-11-16 |
| LIEBERMAN, Gidon, Dr | Secretary | 2014-09-10 | 2018-11-16 |
| LIEBERMAN, Ilan, Dr | Secretary | 2018-11-16 | 2019-11-29 |
| MCHUGH, Lynnsey | Secretary | 2004-07-05 | 2012-03-29 |
| LIEBERMAN, Bernice | Director | 2003-06-05 | 2012-03-29 |
| LIEBERMAN, Brian Abraham | Director | — | 2012-03-29 |
| LIEBERMAN, Gidon | Director | 2012-03-29 | 2014-09-10 |
| LIEBERMAN, Ilan, Dr | Director | 2012-03-29 | 2018-11-16 |
| MCHUGH, Lynnsey | Director | 2012-03-29 | 2015-08-28 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Jonathan Koslover | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
| Dr Deborah Falconer | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 161 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-22 | AA | accounts | accounts with accounts type full |
| 2025-10-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-04-30 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-12-19 | AA | accounts | accounts with accounts type total exemption full |
| 2024-09-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-12-21 | AA | accounts | accounts with accounts type total exemption full |
| 2023-10-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-22 | AA | accounts | accounts with accounts type total exemption full |
| 2022-09-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-12-23 | AA | accounts | accounts with accounts type total exemption full |
| 2021-10-14 | CS01 | confirmation-statement | confirmation statement with updates |
| 2021-08-06 | SH03 | capital | capital return purchase own shares |
| 2021-07-19 | SH06 | capital | capital cancellation shares |
| 2021-01-14 | AA | accounts | accounts with accounts type total exemption full |
| 2020-12-03 | MR04 | mortgage | mortgage satisfy charge full |
| 2020-12-03 | MR04 | mortgage | mortgage satisfy charge full |
| 2020-10-19 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-02-13 | SH01 | capital | capital allotment shares |
| 2020-01-23 | SH06 | capital | capital cancellation shares |
| 2019-12-27 | SH03 | capital | capital return purchase own shares |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
4.09
SAFE
Altman Z″
- Working capital / Total assets 0.182 × 6.56 = +1.20
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.269 × 6.72 = +1.81
- Book equity / Total liabilities 1.034 × 1.05 = +1.09
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory